Shashideep Singhal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shashideep Singhal has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
Sury Anand
Division of Gastroenterology, The Brooklyn Hospital Center, Brooklyn, NY (Manhal Izzy, Kinesh Changela, Dhuha Alhankawi, Nami Safai Haeri, Sury Anand)
28 shared publicationsMojdeh Momeni
Deepanshu Jain, Internal Medicine Department, Albert Einstein Medical Centre, PH 19141, United States
13 shared publicationsSushil Duddempudi
Division of Gastroenterology, The Brooklyn Hospital Center, New York Presbyterian Healthcare System, Brooklyn NY, USA
12 shared publicationsKinesh Changela
Division of Gastroenterology, The Brooklyn Hospital Center, Brooklyn, NY (Manhal Izzy, Kinesh Changela, Dhuha Alhankawi, Nami Safai Haeri, Sury Anand)
10 shared publicationsDeepanshu Jain
Division of Gastroenterology and Hepatology, Department of Digestive Diseases and Transplantation, Internal Medicine, Einstein Healthcare Network, Philadelphia, PA, USA
9 shared publicationsMahesh Krishnaiah
Division of Gastroenterology, The Brooklyn Hospital Center, New York Presbyterian Healthcare System, Brooklyn NY, USA
9 shared publications
Latest Publications
- Open Access
- 30 September 2018
- Published byĀ The Korean Society of Gastrointestinal EndoscopyĀ inĀ Clinical Endoscopy
- Vol.Ā 51 Ā (5) , 450-462
Endoscopic Ultrasound-Guided Gallbladder Drainage Using a Lumen-Apposing Metal Stent for Acute Cholecystitis: A Systematic Review
Surgery remains the standard treatment for acute cholecystitis except in high-risk candidates where percutaneous transhepatic gallbladder drainage (PT-GBD), endoscopic transpapillary cystic duct stenting (ET-CDS), and endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) are potential choices. PT-GBD is contraindicated in patients with coagulopathy or ascites and is not preferred by patients owing to aesthetic reasons. ET-CDS is successful only if the cystic duct can be visualized and cannulated. For 189 patients who underwent EUS-GBD via insertion of a lumen-apposing metal stent (LAMS), the composite technical success rate was 95.2%, which increased to 96.8% when LAMS was combined with co-axial self-expandable metal stent (SEMS). The composite clinical success rate was 96.7%. We observed a small risk of recurrent cholecystitis (5.1%), gastrointestinal bleeding (2.6%) and stent migration (1.1%). Cautery enhanced LAMS significantly decreases the stent deployment time compared to non-cautery enhanced LAMS. Prophylactic placement of a pigtail stent or SEMS through the LAMS avoids re-interventions, particularly in patients, where it is intended to remain in situ indefinitely. Limited evidence suggests that the efficacy of EUS-GBD via LAMS is comparable to that of PT-GBD with the former showing better results in postoperative pain, length of hospitalization, and need for antibiotics. EUS-GBD via LAMS is a safe and efficacious option when performed by experts.
- 30 September 2018
- Published byĀ The Korean Society of Gastrointestinal EndoscopyĀ inĀ Clinical Endoscopy
- Vol.Ā 51 Ā (5) , 450-462
Open AccessEndoscopic Ultrasound-Guided Gallbladder Drainage Using a Lumen-Apposing Metal Stent for Acute Cholecystitis: A Systematic Review
Surgery remains the standard treatment for acute cholecystitis except in high-risk candidates where percutaneous transhepatic gallbladder drainage (PT-GBD), endoscopic transpapillary cystic duct stenting (ET-CDS), and endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) are potential choices. PT-GBD is contraindicated in patients with coagulopathy or ascites and is not preferred by patients owing to aesthetic reasons. ET-CDS is successful only if the cystic duct can be visualized and cannulated. For 189 patients who underwent EUS-GBD via insertion of a lumen-apposing metal stent (LAMS), the composite technical success rate was 95.2%, which increased to 96.8% when LAMS was combined with co-axial self-expandable metal stent (SEMS). The composite clinical success rate was 96.7%. We observed a small risk of recurrent cholecystitis (5.1%), gastrointestinal bleeding (2.6%) and stent migration (1.1%). Cautery enhanced LAMS significantly decreases the stent deployment time compared to non-cautery enhanced LAMS. Prophylactic placement of a pigtail stent or SEMS through the LAMS avoids re-interventions, particularly in patients, where it is intended to remain in situ indefinitely. Limited evidence suggests that the efficacy of EUS-GBD via LAMS is comparable to that of PT-GBD with the former showing better results in postoperative pain, length of hospitalization, and need for antibiotics. EUS-GBD via LAMS is a safe and efficacious option when performed by experts.
- Open Access
- 31 July 2018
- Published byĀ The Korean Society of Gastrointestinal EndoscopyĀ inĀ Clinical Endoscopy
- Vol.Ā 51 Ā (4) , 352-356
Closing the Gaps: Endoscopic Suturing for Large Submucosal and Full-Thickness Defects
This article is a systematic review of relevant literature on endoscopic suturing as a primary closure technique for large submucosal and full-thickness defects after endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and endoscopic full-thickness resection (EFTR). A comprehensive literature search was conducted through 2016 by using PubMed, to find peer-reviewed original articles. The specific factors considered were the procedural indications and details, success rates, clinical outcomes including complications, and study limitations. Six original articles were included in the final review: two with non-human subjects and four with human subjects. The mean success rate of endoscopic suturing was 97.4% (100% for human subjects and 95.4% for non-human subjects). The procedural time ranged from 7 to 89 min. The average size and depth of lesions were 2.71 cm (3.74 cm [human] and 1.96 cm [non-human]) and 1.52 cm, respectively. The technique itself had no reported impact on mortality. In conclusion, endoscopic suturing is a minimally invasive technique for the primary closure of defects caused by EMR, ESD, and EFTR, with a high success and low complication rate.
- 31 July 2018
- Published byĀ The Korean Society of Gastrointestinal EndoscopyĀ inĀ Clinical Endoscopy
- Vol.Ā 51 Ā (4) , 352-356
Open AccessClosing the Gaps: Endoscopic Suturing for Large Submucosal and Full-Thickness Defects
This article is a systematic review of relevant literature on endoscopic suturing as a primary closure technique for large submucosal and full-thickness defects after endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and endoscopic full-thickness resection (EFTR). A comprehensive literature search was conducted through 2016 by using PubMed, to find peer-reviewed original articles. The specific factors considered were the procedural indications and details, success rates, clinical outcomes including complications, and study limitations. Six original articles were included in the final review: two with non-human subjects and four with human subjects. The mean success rate of endoscopic suturing was 97.4% (100% for human subjects and 95.4% for non-human subjects). The procedural time ranged from 7 to 89 min. The average size and depth of lesions were 2.71 cm (3.74 cm [human] and 1.96 cm [non-human]) and 1.52 cm, respectively. The technique itself had no reported impact on mortality. In conclusion, endoscopic suturing is a minimally invasive technique for the primary closure of defects caused by EMR, ESD, and EFTR, with a high success and low complication rate.
- Open Access
- 1 May 2018
- Published byĀ The Korean Society of Gastrointestinal EndoscopyĀ inĀ Clinical Endoscopy
- Vol.Ā 51 Ā (3) , 215-221
Contrast Enhanced Harmonic Endoscopic Ultrasound: A Novel Approach for Diagnosis and Management of Gastrointestinal Stromal Tumors
The histologic analysis of gastrointestinal stromal tumors (GISTs) is a common method to detect the mitotic activity and to subsequently determine the risk of GISTs for malignancy. The potential false negative error due to inadequate yield of specimens and actual determination of malignancy risk requires analysis of the whole tumor. We aimed to assess the role of contrast enhanced endoscopic ultrasound (CE-EUS) in the management of GISTs. Two authors individually did review of English literatures to identify nine peer-reviewed original articles using keywords-contrast endoscopic ultrasound, GIST and submucosal tumor. Studies were heterogeneous in their aims looking either at differentiating submucosal lesions from GISTs, estimating malignant potential of GISTs with histologic correlation or studying the role of angiogenesis in malignant risk stratification. CE-EUS had moderate to high efficacy in differentiating GISTs from alternative submucosal tumors. CE-EUS had a higher sensitivity than EUS-guided fine needle aspiration, contrast computed tomography and Doppler EUS for detection of neo-vascularity within the GISTs. However, the evidence of abnormal angiogenesis within GIST as a prognostic factor needs further validation. CE-EUS is a non-invasive modality, which can help differentiate GISTs and provide valuable assessment of their perfusion patterns to allow better prediction of their malignant potential but more experience is needed.
- 1 May 2018
- Published byĀ The Korean Society of Gastrointestinal EndoscopyĀ inĀ Clinical Endoscopy
- Vol.Ā 51 Ā (3) , 215-221
Open AccessContrast Enhanced Harmonic Endoscopic Ultrasound: A Novel Approach for Diagnosis and Management of Gastrointestinal Stromal Tumors
The histologic analysis of gastrointestinal stromal tumors (GISTs) is a common method to detect the mitotic activity and to subsequently determine the risk of GISTs for malignancy. The potential false negative error due to inadequate yield of specimens and actual determination of malignancy risk requires analysis of the whole tumor. We aimed to assess the role of contrast enhanced endoscopic ultrasound (CE-EUS) in the management of GISTs. Two authors individually did review of English literatures to identify nine peer-reviewed original articles using keywords-contrast endoscopic ultrasound, GIST and submucosal tumor. Studies were heterogeneous in their aims looking either at differentiating submucosal lesions from GISTs, estimating malignant potential of GISTs with histologic correlation or studying the role of angiogenesis in malignant risk stratification. CE-EUS had moderate to high efficacy in differentiating GISTs from alternative submucosal tumors. CE-EUS had a higher sensitivity than EUS-guided fine needle aspiration, contrast computed tomography and Doppler EUS for detection of neo-vascularity within the GISTs. However, the evidence of abnormal angiogenesis within GIST as a prognostic factor needs further validation. CE-EUS is a non-invasive modality, which can help differentiate GISTs and provide valuable assessment of their perfusion patterns to allow better prediction of their malignant potential but more experience is needed.
- Open Access
- 19 April 2018
- Published byĀ S. Karger AGĀ inĀ Digestion
- Vol.Ā 98 Ā (1) , 1-10
Endoscopic Ultrasound Guided Choledocho-Enterostomy by Using Lumen Apposing Metal Stent in Patients with Failed Endoscopic Retrograde Cholangiopancreatography: A Literature Review
Background: Endoscopic retrograde cholangiopancreatography (ERCP) has been the cornerstone in the management of malignant jaundice to provide symptomatic relief and/or to allow chemotherapy. Difficult biliary cannulation or the presence of concomitant duodenal obstruction may lead to its failure. Method: An extensive English literature search was done via PubMed and Google Scholar to identify 13 peer-reviewed original articles. Results: Of 92 patients, 98.9% (91/92) successfully underwent EUS-guided biliary drainage by placement of a lumen-apposing metal stent (LAMS) across extrahepatic biliary tree and small bowel. Although technically challenging, a similar technical success was noted for patients with limited dilation of extrahepatic biliary tree (less than 1 cm) and altered gastrointestinal anatomy (Roux-en-Y, Whipple, or Billroth II). Of 91 patients, 98.9% (90/91) had clinical success. Procedure complications included perforation (2/92; 2.2%) and bleeding (1/92; 1.1%). Stent complications included obstruction (7/91; 7.7%), and migration (1/91; 1.1%) with all responding to endoscopic debridement of food or tumor, placement of plastic pigtail stent through the LAMS, or replacement with a new stent. No procedure-related mortality was noted. Conclusion: In the hands of an expert, EUS-guided biliary drainage with the use of LAMS is an efficacious and safe option for patients with distal malignant biliary stricture, not amenable to ERCP.
- 19 April 2018
- Published byĀ S. Karger AGĀ inĀ Digestion
- Vol.Ā 98 Ā (1) , 1-10
Open AccessEndoscopic Ultrasound Guided Choledocho-Enterostomy by Using Lumen Apposing Metal Stent in Patients with Failed Endoscopic Retrograde Cholangiopancreatography: A Literature Review
Background: Endoscopic retrograde cholangiopancreatography (ERCP) has been the cornerstone in the management of malignant jaundice to provide symptomatic relief and/or to allow chemotherapy. Difficult biliary cannulation or the presence of concomitant duodenal obstruction may lead to its failure. Method: An extensive English literature search was done via PubMed and Google Scholar to identify 13 peer-reviewed original articles. Results: Of 92 patients, 98.9% (91/92) successfully underwent EUS-guided biliary drainage by placement of a lumen-apposing metal stent (LAMS) across extrahepatic biliary tree and small bowel. Although technically challenging, a similar technical success was noted for patients with limited dilation of extrahepatic biliary tree (less than 1 cm) and altered gastrointestinal anatomy (Roux-en-Y, Whipple, or Billroth II). Of 91 patients, 98.9% (90/91) had clinical success. Procedure complications included perforation (2/92; 2.2%) and bleeding (1/92; 1.1%). Stent complications included obstruction (7/91; 7.7%), and migration (1/91; 1.1%) with all responding to endoscopic debridement of food or tumor, placement of plastic pigtail stent through the LAMS, or replacement with a new stent. No procedure-related mortality was noted. Conclusion: In the hands of an expert, EUS-guided biliary drainage with the use of LAMS is an efficacious and safe option for patients with distal malignant biliary stricture, not amenable to ERCP.
- Open Access
- 30 November 2017
- Published byĀ The Korean Society of Gastrointestinal EndoscopyĀ inĀ Clinical Endoscopy
- Vol.Ā 50 Ā (6) , 552-561
Endoscopic Sleeve Gastroplasty - A New Tool to Manage Obesity
Obesity is a growing pandemic across the world. Dietary restrictions and behavior modifications alone have a limited benefit. Bariatric surgery, despite being the current gold standard, has limited acceptance by patients due to cost and associated morbidity. In our review, we have discussed nine original studies describing endoscopic sleeve gastroplasty (ESG). A total of 172 subjects successfully underwent ESG. Of 65 subjects with follow up data, 95.4% (62/65) had intact gastric sleeve confirmed via esophagogastroduodenoscopy or oral contrast study at the end of study specific follow up interval (the longest being 6 months). Individual studies reported a technical success rate for intact gastric sleeve from as low as 50% to as high as 100%. A statistically significant p<0.05) weight loss was reported in seven of the eight studies with available data. None of the patients experienced any intra-procedure complications, and approximately 2.3% (4/172) of patients experienced major post-procedure complications; however, no mortality was reported. Majority of the studies reported relatively high incidence of minor post-procedure complications, which improved with symptomatic treatment alone. Good patient tolerance with comparable clinical efficacy in achieving and sustaining desired weight loss makes ESG an attractive option to consider among other bariatric therapies.
- 30 November 2017
- Published byĀ The Korean Society of Gastrointestinal EndoscopyĀ inĀ Clinical Endoscopy
- Vol.Ā 50 Ā (6) , 552-561
Open AccessEndoscopic Sleeve Gastroplasty - A New Tool to Manage Obesity
Obesity is a growing pandemic across the world. Dietary restrictions and behavior modifications alone have a limited benefit. Bariatric surgery, despite being the current gold standard, has limited acceptance by patients due to cost and associated morbidity. In our review, we have discussed nine original studies describing endoscopic sleeve gastroplasty (ESG). A total of 172 subjects successfully underwent ESG. Of 65 subjects with follow up data, 95.4% (62/65) had intact gastric sleeve confirmed via esophagogastroduodenoscopy or oral contrast study at the end of study specific follow up interval (the longest being 6 months). Individual studies reported a technical success rate for intact gastric sleeve from as low as 50% to as high as 100%. A statistically significant p<0.05) weight loss was reported in seven of the eight studies with available data. None of the patients experienced any intra-procedure complications, and approximately 2.3% (4/172) of patients experienced major post-procedure complications; however, no mortality was reported. Majority of the studies reported relatively high incidence of minor post-procedure complications, which improved with symptomatic treatment alone. Good patient tolerance with comparable clinical efficacy in achieving and sustaining desired weight loss makes ESG an attractive option to consider among other bariatric therapies.
- Open Access
- 1 September 2017
- Published byĀ Romanian Society of Gastroenterology and HepatologyĀ inĀ Journal of Gastrointestinal and Liver Diseases
- Vol.Ā 26 Ā (3) , 291-297
Volumetric Laser Endomicroscopy for Barrettās Esophagus ā Looking at the Fine Print
Barrettās esophagus (BE) is a premalignant condition. The incidence of adenocarcinoma in BE has been reported to be between 0.1-3%. Dysplasia in BE is patchy and extensive biopsy sampling is labor intensive, low yield and does not eliminate the sampling error completely. Volumetric laser endomicroscopy (VLE) is expected to enable endoscopists to do targeted biopsy of dysplastic/cancerous lesions (not visible on white light endoscopy) among patients with BE. We reviewed 7 studies with a total of 62 subjects who had undergone VLE. Of 34 patients with available data, VLE correlated with histology in 17 subjects (50%). It missed the underlying diagnosis in one subject (2.9%). VLE led to inadvertent biopsy in 16 patients (47.1%), and led or would have led to upstaging of disease in 11 subjects (32.4%). In the entire cohort, the sensitivity, specificity, positive predictive value and negative predictive value (NPV) of VLE for diagnosis of dysplasia, buried Barrettās or intramucosal carcinoma was 92.3%, 23.8%, 42.9% and 83.3%, respectively. High sensitivity and NPV can potentially help space out the surveillance intervals. Low specificity does lead to a high number of biopsies, which are likely less than non targeted biopsies. Volumetric laser endomicroscopy is a safe and sensitive test to identify mucosal lesions in patients with BE which are invisible under standard white light endoscopy.Abbreviations: BE: Barrettās Esophagus; BB: Buried Barrettās; EAC: Esophageal adenocarcinoma; EDS: Evans Dysplasia Score; EMR: Endoscopic Mucosal Resection; GERD: Gastro-esophageal reflux disease; HGD: High grade dysplasia; IMC: Intra-mucosal adenocarcinoma; LGD: Low grade dysplasia; NBI: Narrow Band Imaging; OCT-SI: Optical Coherence Tomography Scoring Index; RFA: Radiofrequency ablation; SGS: Sub-squamous glandular structures; VLE: Volumetric Laser Endomicroscopy; WLE: White Light Endoscopy.
- 1 September 2017
- Published byĀ Romanian Society of Gastroenterology and HepatologyĀ inĀ Journal of Gastrointestinal and Liver Diseases
- Vol.Ā 26 Ā (3) , 291-297
Open AccessVolumetric Laser Endomicroscopy for Barrettās Esophagus ā Looking at the Fine Print
Barrettās esophagus (BE) is a premalignant condition. The incidence of adenocarcinoma in BE has been reported to be between 0.1-3%. Dysplasia in BE is patchy and extensive biopsy sampling is labor intensive, low yield and does not eliminate the sampling error completely. Volumetric laser endomicroscopy (VLE) is expected to enable endoscopists to do targeted biopsy of dysplastic/cancerous lesions (not visible on white light endoscopy) among patients with BE. We reviewed 7 studies with a total of 62 subjects who had undergone VLE. Of 34 patients with available data, VLE correlated with histology in 17 subjects (50%). It missed the underlying diagnosis in one subject (2.9%). VLE led to inadvertent biopsy in 16 patients (47.1%), and led or would have led to upstaging of disease in 11 subjects (32.4%). In the entire cohort, the sensitivity, specificity, positive predictive value and negative predictive value (NPV) of VLE for diagnosis of dysplasia, buried Barrettās or intramucosal carcinoma was 92.3%, 23.8%, 42.9% and 83.3%, respectively. High sensitivity and NPV can potentially help space out the surveillance intervals. Low specificity does lead to a high number of biopsies, which are likely less than non targeted biopsies. Volumetric laser endomicroscopy is a safe and sensitive test to identify mucosal lesions in patients with BE which are invisible under standard white light endoscopy.Abbreviations: BE: Barrettās Esophagus; BB: Buried Barrettās; EAC: Esophageal adenocarcinoma; EDS: Evans Dysplasia Score; EMR: Endoscopic Mucosal Resection; GERD: Gastro-esophageal reflux disease; HGD: High grade dysplasia; IMC: Intra-mucosal adenocarcinoma; LGD: Low grade dysplasia; NBI: Narrow Band Imaging; OCT-SI: Optical Coherence Tomography Scoring Index; RFA: Radiofrequency ablation; SGS: Sub-squamous glandular structures; VLE: Volumetric Laser Endomicroscopy; WLE: White Light Endoscopy.
- 30 May 2017
- Published byĀ Georg Thieme Verlag KGĀ inĀ Endoscopy
- Vol.Ā 49 Ā (07) , E171-E172
Endoscopic full-thickness resection of a non-lifting large laterally spreading flat colonic polyp
Resection of a non-lifting large laterally spreading flat colonic polyp can be challenging. A 44-year-old Hispanic woman with a history of hereditary non-polyposis colorectal cancer syndrome (HNPCC) was referred for removal of a laterally spreading polyp. Colonoscopy showed a 2-cm laterally spreading flat polyp in the proximal transverse colon ([Video 1]; [Fig. 1a]). Submucosal injection was performed using a solution of saline, methylene blue, and epinephrine (1:200 000) but the polyp could not be lifted despite injecting 100 mL of the solution ([Fig. 1 b]). Because of the flat and central non-lifting nature of the polyp, it could not be engaged with available snares. A decision was made to perform an endoscopic full-thickness resection using a band device. Video 1 Endoscopic full-thickness resection of a non-lifting large laterally spreading flat colonic polyp, with subsequent computed tomography scan and histology images. A band mucosectomy kit was used, with a band being placed at the base of the polyp. The resection was performed using a hot snare below the band. After the resection, a full-thickness defect of approximately 2 cm was seen at the site of the resection ([Fig. 1 c]). This was then completely closed using a 14/6 type ātā over-the-scope clip (OTSC) ([Fig. 1 d]). A computed tomography (CT) scan of the abdomen with oral contrast after the procedure showed free peritoneal air but no leak of the oral contrast at the site of OTSC. The patient reported minimal abdominal discomfort due to the free peritoneal carbon dioxide for a few hours after the procedure, which resolved spontaneously. The patient was kept under observation for 12 hours and discharged on prophylactic antibiotics. Pathology revealed the full-thickness resection of a tubular adenoma with areas of focal high grade dysplasia and negative margins. We conclude that full-thickness resection of a large non-lifting laterally spreading polyp can be performed using a band endoscopic mucosal resection technique and an OTSC can be used for successful closure of the full-thickness colonic defect, thereby decreasing the morbidity associated with surgery. Endoscopy_UCTN_Code_TTT_1AO_2AG
- 30 May 2017
- Published byĀ Georg Thieme Verlag KGĀ inĀ Endoscopy
- Vol.Ā 49 Ā (07) , E171-E172
Endoscopic full-thickness resection of a non-lifting large laterally spreading flat colonic polyp
Resection of a non-lifting large laterally spreading flat colonic polyp can be challenging. A 44-year-old Hispanic woman with a history of hereditary non-polyposis colorectal cancer syndrome (HNPCC) was referred for removal of a laterally spreading polyp. Colonoscopy showed a 2-cm laterally spreading flat polyp in the proximal transverse colon ([Video 1]; [Fig. 1a]). Submucosal injection was performed using a solution of saline, methylene blue, and epinephrine (1:200 000) but the polyp could not be lifted despite injecting 100 mL of the solution ([Fig. 1 b]). Because of the flat and central non-lifting nature of the polyp, it could not be engaged with available snares. A decision was made to perform an endoscopic full-thickness resection using a band device. Video 1 Endoscopic full-thickness resection of a non-lifting large laterally spreading flat colonic polyp, with subsequent computed tomography scan and histology images. A band mucosectomy kit was used, with a band being placed at the base of the polyp. The resection was performed using a hot snare below the band. After the resection, a full-thickness defect of approximately 2 cm was seen at the site of the resection ([Fig. 1 c]). This was then completely closed using a 14/6 type ātā over-the-scope clip (OTSC) ([Fig. 1 d]). A computed tomography (CT) scan of the abdomen with oral contrast after the procedure showed free peritoneal air but no leak of the oral contrast at the site of OTSC. The patient reported minimal abdominal discomfort due to the free peritoneal carbon dioxide for a few hours after the procedure, which resolved spontaneously. The patient was kept under observation for 12 hours and discharged on prophylactic antibiotics. Pathology revealed the full-thickness resection of a tubular adenoma with areas of focal high grade dysplasia and negative margins. We conclude that full-thickness resection of a large non-lifting laterally spreading polyp can be performed using a band endoscopic mucosal resection technique and an OTSC can be used for successful closure of the full-thickness colonic defect, thereby decreasing the morbidity associated with surgery. Endoscopy_UCTN_Code_TTT_1AO_2AG
- 1 May 2017
- Published byĀ ElsevierĀ inĀ Gastrointestinal Endoscopy
- Vol.Ā 85 Ā (5) , AB144
1111 Feasibility, Safety, and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) of the Pancreatic Lesions: Single Center Us Experience
- 1 May 2017
- Published byĀ ElsevierĀ inĀ Gastrointestinal Endoscopy
- Vol.Ā 85 Ā (5) , AB144
1111 Feasibility, Safety, and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) of the Pancreatic Lesions: Single Center Us Experience
- 1 May 2017
- Published byĀ ElsevierĀ inĀ Gastrointestinal Endoscopy
- Vol.Ā 85 Ā (5) , AB139
1099 Endoscopic Ultrasound-Guided Hemostasis of Rectal Varices
- 1 May 2017
- Published byĀ ElsevierĀ inĀ Gastrointestinal Endoscopy
- Vol.Ā 85 Ā (5) , AB139
1099 Endoscopic Ultrasound-Guided Hemostasis of Rectal Varices
- 20 February 2017
- Published byĀ ElsevierĀ inĀ Gastrointestinal Endoscopy
- Vol.Ā 85 Ā (6) , 1303-1304
Overtube-assisted pneumatic dilation for achalasia in megaesophagus
- 20 February 2017
- Published byĀ ElsevierĀ inĀ Gastrointestinal Endoscopy
- Vol.Ā 85 Ā (6) , 1303-1304
Overtube-assisted pneumatic dilation for achalasia in megaesophagus